BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34080686)

  • 1. Progress and lack of progress in hyperhidrosis research 2015-2020. A concise systematic review.
    Kristensen JK; Nielsen C
    Int J Dermatol; 2022 Feb; 61(2):148-157. PubMed ID: 34080686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventional management of hyperhidrosis in secondary care: a systematic review.
    Wade R; Llewellyn A; Jones-Diette J; Wright K; Rice S; Layton AM; Levell NJ; Craig D; Woolacott N
    Br J Dermatol; 2018 Sep; 179(3):599-608. PubMed ID: 29573391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for hyperhidrosis in secondary care: a systematic review and value-of-information analysis.
    Wade R; Rice S; Llewellyn A; Moloney E; Jones-Diette J; Stoniute J; Wright K; Layton AM; Levell NJ; Stansby G; Craig D; Woolacott N
    Health Technol Assess; 2017 Dec; 21(80):1-280. PubMed ID: 29271741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum Toxin Versus Placebo: A Meta-Analysis of Treatment and Quality-of-life Outcomes for Hyperhidrosis.
    Obed D; Salim M; Bingoel AS; Hofmann TR; Vogt PM; Krezdorn N
    Aesthetic Plast Surg; 2021 Aug; 45(4):1783-1791. PubMed ID: 33619611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-Arm Guided Percutaneous Radiofrequency Thoracic Sympathectomy for Treatment of Primary Palmar Hyperhidrosis in Comparison with Local Botulinum Toxin Type A Injection, Randomized Trial.
    Mostafa TAH; Hamed AA; Mohammed BM; El Sheikh NA; Shama AAA
    Pain Physician; 2019 Nov; 22(6):591-599. PubMed ID: 31775406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.
    Naumann MK; Hamm H; Lowe NJ;
    Br J Dermatol; 2002 Dec; 147(6):1218-26. PubMed ID: 12452874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary study of painless and effective transdermal botulinum toxin A delivery by jet nebulization for treatment of primary hyperhidrosis.
    Iannitti T; Palmieri B; Aspiro A; Di Cerbo A
    Drug Des Devel Ther; 2014; 8():931-5. PubMed ID: 25075176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sweat and tears: treating the patient with primary hyperhidrosis.
    Wheeler T
    Br J Nurs; 2012 Apr 12-25; 21(7):408, 410-2. PubMed ID: 22585018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
    Rosell K; Hymnelius K; Swartling C
    Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The etiology, diagnosis, and management of hyperhidrosis: A comprehensive review: Therapeutic options.
    Nawrocki S; Cha J
    J Am Acad Dermatol; 2019 Sep; 81(3):669-680. PubMed ID: 30710603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
    Schnider P; Moraru E; Kittler H; Binder M; Kranz G; Voller B; Auff E
    Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of palmar hyperhidrosis - a systematic review.
    Chudry H
    Int J Dermatol; 2022 Nov; 61(11):1303-1310. PubMed ID: 34653261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable botulinum toxin as a treatment for plantar hyperhidrosis: a case study.
    Vlahovic TC; Dunn SP; Blau JC; Gauthier C
    J Am Podiatr Med Assoc; 2008; 98(2):156-9. PubMed ID: 18347128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treated patients in survey: High satisfaction with botulinum toxin in palmar hyperhidrosis].
    Deebaj R; Emtestam L; Lundeberg L; Brandin Samuelsson K; Girnita A
    Lakartidningen; 2015 Jan; 112():. PubMed ID: 25625725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment approaches and outcomes associated with the use of abobotulinumtoxinA for the treatment of hyperhidrosis: A systematic review.
    Galadari H; Galadari I; Smit R; Prygova I; Redaelli A
    J Am Acad Dermatol; 2021 Nov; 85(5):1121-1129. PubMed ID: 32781184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hyperhidrosis with botulinum toxin.
    Doft MA; Hardy KL; Ascherman JA
    Aesthet Surg J; 2012 Feb; 32(2):238-44. PubMed ID: 22328694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intradermal injection with iontophoresis of abobotulinum toxin A for the treatment of primary axillary hyperhidrosis: a randomized, controlled trial.
    Montaser-Kouhsari L; Zartab H; Fanian F; Noorian N; Sadr B; Nassiri-Kashani M; Firooz A
    J Dermatolog Treat; 2014 Aug; 25(4):337-41. PubMed ID: 23106157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhidrosis: evolving therapies for a well-established phenomenon.
    Eisenach JH; Atkinson JL; Fealey RD
    Mayo Clin Proc; 2005 May; 80(5):657-66. PubMed ID: 15887434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapeutic strategies for hyperhidrosis: a review.
    Togel B; Greve B; Raulin C
    Eur J Dermatol; 2002; 12(3):219-23. PubMed ID: 11978559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for effectiveness of botulinum toxin for hyperhidrosis.
    Bhidayasiri R; Truong DD
    J Neural Transm (Vienna); 2008; 115(4):641-5. PubMed ID: 17885725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.